VITALY KRAMER: Open Payments
NPI 1649672650 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,449 in 96 payments from 18 companies in 2025. Trend: 2023 $3,525 · 2024 $3,422 · 2025 $2,449
Food & beverage: $1,975Consulting: $375Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 24 | $557 |
| LEO Pharma Inc. | 6 | $446 |
| Incyte Corporation | 10 | $215 |
| ABBVIE INC. | 13 | $209 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 7 | $163 |
| Novartis Pharmaceuticals Corporation | 7 | $147 |
| Lilly USA, LLC | 5 | $146 |
| Botanix SB Inc | 3 | $91 |
| Organon LLC | 4 | $85 |
| MAYNE PHARMA COMMERCIAL LLC | 3 | $73 |
Products named: TREMFYA, ADBRY, OPZELURA, ILUMYA, EBGLYSS, RINVOQ, SKYRIZI, DUPIXENT.
Industry payments across NY — which companies pay providers there.
